ADMA

$9.39-1.57%

ADMA BIOLOGICS, INC.

Market Cap

$2.1B

Sector

Materials

Industry

Biotechnology

Beta

0.69

5yr monthly vs SPY

Price Chart

Loading…

Signals

Insider Velocity

Market & Alt Data

News

15

recent articles

Analyst Consensus

Strong Buy

11 analysts

Buy Activity

Buy Velocity Score

24.85x

Current Rate (90d)

504.44/mo

Baseline Rate

0.00/mo

Unique Buyers (90d)

2

Sell Activity

Sell Velocity Score

21.03x

Sell Rate (90d)

345.51/mo

Sell Baseline

40.82/mo

Unique Sellers (90d)

2

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-05-27	2026-05-28	Grossman Jerrold B	Director	Purchase	6,400	$7.91	$51K	520.3K	View
2026-05-12	2026-05-14	Grossman Jerrold B	Director	Purchase	12.5K	$8.01	$100K	513.9K	View
2026-05-11	2026-05-12	Grossman Jerrold B	Director	Purchase	12.5K	$8.01	$100K	501.4K	View
2026-03-16	2026-03-17	Grossman Adam S	Director & President and CEO	Sale	21.0K	$15.16	$318K	2.11M	View
2026-03-09	2026-03-10	Kestenberg-Messina Kaitlin M.	COO and SVP, Compliance	Sale	10.1K	$15.63	$158K	466.6K	View

1–5 of 9

1 / 2

Recent News

Adma Biologics (ADMA) Falls More Steeply Than Broader Market: What Investors Need to Know

Yahoo Finance · 2026-09-10

IonQ Investor Day Unveils Superion Roadmap, SkyWater-Powered Growth Strategy

Yahoo Finance · 2026-09-09

Adma Biologics (ADMA) Is Considered a Good Investment by Brokers: Is That True?

Yahoo Finance · 2026-09-08

Adma Biologics (ADMA) Down 4.8% Since Last Earnings Report: Can It Rebound?

Yahoo Finance · 2026-09-04

Informational purposes only, not investment advice.